A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

Top Cited Papers
Open Access
Abstract
EK1 is a broad-spectrum human coronavirus fusion inhibitor for combating infection of current and emerging coronaviruses.
Funding Information
  • National Natural Science Foundation of China (81661128041)
  • National Natural Science Foundation of China (81672019)
  • National Natural Science Foundation of China (81822045)
  • National Natural Science Foundation of China (31600619)
  • Ministry of Science and Technology of the People’s Republic of China (2016YFC1201000)
  • Ministry of Science and Technology of the People’s Republic of China (2016YFC1202901)
  • the Shanghai Rising-Star Program (16QA1400300)
  • National Megaprojects of China for Major Infectious Diseases (2018ZX10301403)
  • the Sanming Project of Medicine in Shenzhen
  • Ministry of Science and Technology of the People’s Republic of China (2016YFC1200405)

This publication has 76 references indexed in Scilit: